Xu X[Author] - Search Results

Year	Number of Results
1963	1
1979	4
1980	3
1981	9
1982	9
1983	12
1984	24
1985	17
1986	15
1987	39
1988	38
1989	32
1990	44
1991	55
1992	72
1993	77
1994	130
1995	127
1996	151
1997	149
1998	141
1999	203
2000	219
2001	292
2002	358
2003	380
2004	487
2005	604
2006	639
2007	751
2008	975
2009	1107
2010	1295
2011	1516
2012	1729
2013	2137
2014	2502
2015	2809
2016	2896
2017	3173
2018	3644
2019	4066
2020	4900
2021	1159

1

Next-Generation Vaccines: Nanoparticle-Mediated DNA and mRNA Delivery.

Ho W, Gao M, Li F, Li Z, Zhang XQ, Xu X. Ho W, et al. Among authors: xu x. Adv Healthc Mater. 2021 Jan 18:e2001812. doi: 10.1002/adhm.202001812. Online ahead of print. Adv Healthc Mater. 2021. PMID: 33458958 Review.

2

Nature's gift to neuroscience.

Alcedo J, Jin Y, Portman DS, Prahlad V, Raizen D, Rapti G, Xu XZS, Zhang Y, Wu CF. Alcedo J, et al. Among authors: xu xzs. J Neurogenet. 2020 Sep-Dec;34(3-4):223-224. doi: 10.1080/01677063.2020.1841760. J Neurogenet. 2020. PMID: 33446019 No abstract available.

3

Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy.

Somasundaram R, Connelly T, Choi R, Choi H, Samarkina A, Li L, Gregorio E, Chen Y, Thakur R, Abdel-Mohsen M, Beqiri M, Kiernan M, Perego M, Wang F, Xiao M, Brafford P, Yang X, Xu X, Secreto A, Danet-Desnoyers G, Traum D, Kaestner KH, Huang AC, Hristova D, Wang J, Fukunaga-Kalabis M, Krepler C, Ping-Chen F, Zhou X, Gutierrez A, Rebecca VW, Vonteddu P, Dotiwala F, Bala S, Majumdar S, Dweep H, Wickramasinghe J, Kossenkov AV, Reyes-Arbujas J, Santiago K, Nguyen T, Griss J, Keeney F, Hayden J, Gavin BJ, Weiner D, Montaner LJ, Liu Q, Peiffer L, Becker J, Burton EM, Davies MA, Tetzlaff MT, Muthumani K, Wargo JA, Gabrilovich D, Herlyn M. Somasundaram R, et al. Among authors: xu x. Nat Commun. 2021 Jan 12;12(1):346. doi: 10.1038/s41467-020-20600-7. Nat Commun. 2021. PMID: 33436641 Free PMC article.

4

Circular RNAs in body fluids as cancer biomarkers: the new frontier of liquid biopsies.

Wang S, Zhang K, Tan S, Xin J, Yuan Q, Xu H, Xu X, Liang Q, Christiani DC, Wang M, Liu L, Du M. Wang S, et al. Among authors: xu x. Mol Cancer. 2021 Jan 11;20(1):13. doi: 10.1186/s12943-020-01298-z. Mol Cancer. 2021. PMID: 33430880 Free PMC article. Review.

5

The Source of Glycolytic Intermediates in Mammalian Tissues.

TeSlaa T, Bartman CR, Jankowski CSR, Zhang Z, Xu X, Xing X, Wang L, Lu W, Hui S, Rabinowitz JD. TeSlaa T, et al. Among authors: xu x. Cell Metab. 2021 Feb 2;33(2):367-378.e5. doi: 10.1016/j.cmet.2020.12.020. Epub 2021 Jan 19. Cell Metab. 2021. PMID: 33472024

6

Normal and defective pathways in biogenesis and maintenance of the insulin storage pool.

Liu M, Huang Y, Xu X, Li X, Alam M, Arunagiri A, Haataja L, Ding L, Wang S, Itkin-Ansari P, Kaufman RJ, Tsai B, Qi L, Arvan P. Liu M, et al. Among authors: xu x. J Clin Invest. 2021 Jan 19;131(2):e142240. doi: 10.1172/JCI142240. J Clin Invest. 2021. PMID: 33463547 Free article. Review.

7

The TGF-β superfamily cytokine Activin-A is induced during autoimmune neuroinflammation and drives pathogenic Th17 cell differentiation.

Wu B, Zhang S, Guo Z, Bi Y, Zhou M, Li P, Seyedsadr M, Xu X, Li JL, Markovic-Plese S, Wan YY. Wu B, et al. Among authors: xu x. Immunity. 2021 Feb 9;54(2):308-323.e6. doi: 10.1016/j.immuni.2020.12.010. Epub 2021 Jan 8. Immunity. 2021. PMID: 33421362

8

Histone crotonylation promotes mesoendodermal commitment of human embryonic stem cells.

Fang Y, Xu X, Ding J, Yang L, Doan MT, Karmaus PWF, Snyder NW, Zhao Y, Li JL, Li X. Fang Y, et al. Among authors: xu x. Cell Stem Cell. 2021 Jan 8:S1934-5909(20)30593-2. doi: 10.1016/j.stem.2020.12.009. Online ahead of print. Cell Stem Cell. 2021. PMID: 33450185

9

A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells.

Shen S, Xu X, Lin S, Zhang Y, Liu H, Zhang C, Mo R. Shen S, et al. Among authors: xu x. Nat Nanotechnol. 2021 Jan;16(1):104-113. doi: 10.1038/s41565-020-00793-0. Epub 2021 Jan 12. Nat Nanotechnol. 2021. PMID: 33437035

10

Nuciferine protects against folic acid-induced acute kidney injury by inhibiting ferroptosis.

Li D, Liu B, Fan Y, Liu M, Han B, Meng Y, Xu X, Song Z, Liu X, Hao Q, Duan X, Nakai A, Chang Y, Cao P, Tan K. Li D, et al. Among authors: xu x. Br J Pharmacol. 2021 Mar;178(5):1182-1199. doi: 10.1111/bph.15364. Br J Pharmacol. 2021. PMID: 33450067

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results